List of authorized vaccines and treatments for COVID-19

Product name Company name Product type Status Date of approval Approved for different indication ID
EVUSHELD (cilgavimab / tixagevimab) AstraZeneca Canada Inc. Treatment Authorized No 109
Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) Medicago Inc Vaccine Authorized No 106
NUVAXOVID (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized No 104
PAXLOVID (nirmatrelvir / ritonavir) Pfizer Canada ULC Treatment Authorized No 102
Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Authorized By Interim Order No 36
Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Authorized By Interim Order No 34
JCOVDEN (Ad26.COV2.S [recombinant]) Previously Janssen COVID-10 Vaccine Janssen Inc Vaccine Authorized By Interim Order No 27
Vaxzevria (ChAdOx1-S [recombinant]) previously Astrazeneca Covid-19 Vaccine AstraZeneca Canada Inc. Vaccine Authorized By Interim Order No 28
COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order No 29
SPIKEVAX (elasomeran) previously COVID-19 Vaccine Moderna ModernaTX, Inc. Vaccine Authorized By Interim Order No 15
Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order No 16
Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order No 8
Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized No 9
Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) Medicago Inc Vaccine Under review Under review No 38
Olumiant (baricitinib) Eli Lilly Canada Inc Treatment Under review Under review Yes 39
Regdanvimab (regdanvimab) Celltrion HealthCare Co Ltd Treatment Under review Under review No 53
COVID-19 Vaccine Moderna – Application for Pediatric Use (ages 12-17) (mRNA-1273 SARS-CoV-2) ModernaTX, Inc. Vaccine Under review Under review No 55
Nitric oxide (nitric oxide) Sanotize Research & Development Corp. Treatment Under review Under review Yes 76
Covaxin (whole virion inactivated corona virus) Vaccigen Ltd Vaccine Under review Under review No 77
Leronlimab (leronlimab) CytoDyn, Inc. Treatment Under review Under review No 35
Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) Eli Lilly Canada Inc Treatment Under review Under review No 32
Novavax COVID-19 Vaccine (NVX-CoV2373) Novavax Inc Vaccine Under review Under review No 31
Favipiravir (favipiravir) Dr Reddys Laboratories Ltd Treatment Under review Under review 17